Literature DB >> 11040848

Infective endocarditis in patients receiving long-term hemodialysis.

J T McCarthy1, J M Steckelberg.   

Abstract

OBJECTIVE: To ascertain the predominant characteristics of patients receiving long-term dialysis who develop infective endocarditis (IE). PATIENTS AND METHODS: We reviewed the records of all chronic hemodialysis patients who had IE at Mayo Clinic, Rochester, Minn, between 1983 and 1997.
RESULTS: Twenty episodes of IE occurred in 17 patients. One patient had 3 episodes of IE, and 1 patient had 2 episodes of IE; each episode was caused by a different organism. The mean +/- SD age of our patients was 63 +/- 11 years; there were 13 males; 6 patients had diabetes mellitus; and the mean +/- SD duration of hemodialysis prior to IE was 24.2 +/- 20.5 months. This analysis included 10 episodes of IE (occurring in 9 patients) within the Mayo Clinic Dialysis System during which time 223,358 hemodialysis treatments were delivered, giving a rate of 10 IE episode per 223,336 hemodialysis treatments. Among all 20 IE episodes, there were 14 synthetic arteriovenous grafts, 4 permanent venous dialysis catheters, 2 temporary venous dialysis catheters, and 2 native arteriovenous fistulas (2 accesses in 2 patients), and access had been in place for a mean +/- SD of 15.9 +/- 18.6 months. The portal of infection was the hemodialysis access in 13 episodes of IE. The causative organisms for IE were Staphylococcus aureus in 8 cases, Enterococcus sp in 4 cases, viridans streptococcus in 3 cases, Staphylococcus epidermidis in 2 cases, and 1 case each of Streptococcus bovis, group G beta-hemolytic streptococcus, and Aspergillus sp. The mitral valve was involved in 9 cases, the aortic valve was involved in 5 cases, and the tricuspid and pulmonic valves were involved in 1 case each. Patient survival (after the first episode of IE) was 71% at 30 days; 53% at 60 days; and 35% at 1 year. Echocardiography was performed in 19 episodes of IE. The transthoracic echocardiogram was 62.5% sensitive and 40% specific for the presence of definite or probable vegetations. Univariate analysis for factors affecting 60-day survival show that presence of right-sided IE, vegetation size greater than 2.0 cm3, diagnosis of diabetes mellitus, and initial leukocyte count greater than 12.5 x 10(9)/L were poor prognostic factors. Aortic valve involvement carried a better prognosis.
CONCLUSIONS: Infective endocarditis in hemodialysis patients is relatively infrequent but has a high mortality. Patients with synthetic intravascular dialysis angioaccess (synthetic grafts and venous catheters) are more likely to develop IE than patients with native arteriovenous fistulas. Transesophageal echocardiography is a preferred echocardiographic study for suspected cases of IE. Prolonged antibiotic therapy is needed for all patients, and close monitoring is needed for patients with right-sided IE, large vegetations, diabetes mellitus, and an elevated leukocyte count.

Entities:  

Mesh:

Year:  2000        PMID: 11040848     DOI: 10.4065/75.10.1008

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  21 in total

1.  Complications of native and prosthetic valve infective endocarditis: update in 2006.

Authors:  Ignasi Anguera; Ana del Río; Asunción Moreno; Carlos Paré; Carlos A Mestres; José M Miró
Journal:  Curr Infect Dis Rep       Date:  2006-06       Impact factor: 3.725

2.  Epidemiological and mortality trends in infective endocarditis, a 17-year population-based prospective study.

Authors:  Alberto Cresti; Mario Chiavarelli; Marco Scalese; Cesira Nencioni; Silvia Valentini; Francesco Guerrini; Incoronata D'Aiello; Andrea Picchi; Francesco De Sensi; Gilbert Habib
Journal:  Cardiovasc Diagn Ther       Date:  2017-02

3.  Contemporary management and outcomes of infective tunnelled haemodialysis catheter-related right atrial thrombi: a case series and literature review.

Authors:  Min Sen Yew; Andrew Michael Weng Meng Leong
Journal:  Singapore Med J       Date:  2019-10-08       Impact factor: 1.858

Review 4.  Oro-dental health in children with chronic renal failure and after renal transplantation: a clinical review.

Authors:  Victoria S Lucas; Graham J Roberts
Journal:  Pediatr Nephrol       Date:  2005-06-10       Impact factor: 3.714

5.  Infective Endocarditis in Patients with Kidney Failure: Chronic Dialysis and Kidney Transplant.

Authors:  James H.E. Ireland; James T. McCarthy
Journal:  Curr Infect Dis Rep       Date:  2003-08       Impact factor: 3.725

6.  Infective endocarditis in hemodialysis patients: clinical features, echocardiographic data and outcome: a 10-year descriptive analysis.

Authors:  Sofiene Rekik; Imen Trabelsi; Mourad Hentati; Adnene Hammami; Mounir Ben Jemaa; Jamil Hachicha; Samir Kammoun
Journal:  Clin Exp Nephrol       Date:  2009-04-21       Impact factor: 2.801

7.  Successful surgical intervention for active infective endocarditis on a hemodialysis patient with cerebral infarction and disseminated intravascular coagulopathy.

Authors:  Masayuki Sakaki; Toshiki Takahashi; Yuji Miyamoto; Yoshiki Sawa; Hikaru Matsuda
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2004-02

8.  Risk of Infective Endocarditis in Patients with End Stage Renal Disease.

Authors:  Mavish S Chaudry; Nicholas Carlson; Gunnar H Gislason; Anne-Lise Kamper; Marianne Rix; Vance G Fowler; Christian Torp-Pedersen; Niels E Bruun
Journal:  Clin J Am Soc Nephrol       Date:  2017-10-03       Impact factor: 8.237

9.  Long-term survival of dialysis patients with bacterial endocarditis undergoing valvular replacement surgery in the United States.

Authors:  Maxwell D Leither; Gautam R Shroff; Shu Ding; David T Gilbertson; Charles A Herzog
Journal:  Circulation       Date:  2013-06-19       Impact factor: 29.690

Review 10.  Infective endocarditis caused by Salmonella enteritidis in a dialysis patient: a case report and literature review.

Authors:  Yusuke Tsugawa; Miyuki Futatsuyama; Keiichi Furukawa; Fumika Taki; Yuji Nishizaki; Keiichi Tamagaki; Yuki Kaneshiro; Yasuhiro Komatsu
Journal:  BMC Infect Dis       Date:  2009-09-29       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.